Anti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/refractory CD19+ ALL and NHL

计划入组 29 人 · 首次发布于 2017 年 12 月 14 日

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia

计划入组 167 人 · 首次发布于 2014 年 1 月 7 日

Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for CD19-positive ALL

计划入组 20 人 · 首次发布于 2020 年 3 月 11 日

Anti-CD99-A192

Anti-CD99 antibody(MSKCC)

Anti-CD99-doxorubicin ADC(Nanovalent)

Single-Cell Analysis Reveals BRCA1 Mutation Drives Distinct Tumor Microenvironments in Triple-Negative Breast Cancer

CD99L2 Identified as Novel Disease Gene for Spastic Ataxia and Hereditary Spastic Paraplegia

FDA Approves Autolus' Aucatzyl, a CD19 CAR T-cell Therapy for B-cell ALL